AI Insight
Lesion network mapping (LNM) is a technique that links brain lesions occurring in different anatomical locations to shared functional networks associated with specific symptoms. This study introduces a robust LNM framework (rLNM) that incorporates null models to rigorously test whether identified networks are statistically valid and genuinely specific to particular symptoms rather than reflecting general or spurious patterns. Tested across 10 lesion-based conditions (333 lesions) and 4 task-based conditions (706 experiments), rLNM successfully identifies biologically meaningful, symptom-specific networks while controlling for false positives.
Why it matters
Improving the statistical reliability and specificity of lesion network mapping has direct implications for understanding the brain basis of neurological and psychiatric conditions, potentially guiding more targeted therapeutic interventions such as neuromodulation or surgical planning.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Lesion network mapping (LNM) and its derivatives successfully integrate anatomically distributed brain loci into common symptom-associated functional networks, however, their statistical validity and specificity have recently become topics of debate. Here, we introduce a null-model based robust LNM (rLNM) framework to perform sensitivity and symptom-specificity testing. Across multiple lesion-based (10 conditions, 333 lesions) and task-based (4 conditions, 706 experiments) datasets, rLNM reveals biologically meaningful and symptom-specific networks while effectively controlling for false positives.
Source: Robust lesion network mapping reveals genuine symptom-specific networks